tiprankstipranks
Trending News
More News >
THG (GB:THG)
LSE:THG
Advertisement

THG (THG) AI Stock Analysis

Compare
157 Followers

Top Page

GB:THG

THG

(LSE:THG)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
31.00p
▼(-13.46% Downside)
THG's overall stock score is primarily influenced by its financial challenges, including declining revenues and high leverage. While technical indicators suggest a bearish trend, strategic achievements in the earnings call, such as growth in THG Nutrition and balance sheet improvements, provide some optimism. Valuation remains a concern with negative earnings and no dividend yield.
Positive Factors
THG Nutrition Division Growth
The growth in THG Nutrition indicates strong demand and successful market expansion, which could lead to sustained revenue increases and enhanced brand recognition globally.
Balance Sheet Strengthening
Reducing debt and extending financial facilities improve financial stability and flexibility, allowing THG to invest in growth opportunities and withstand economic fluctuations.
Myprotein Brand Growth and Expansion
The successful rebrand and expansion into major retail channels like Walmart enhance Myprotein's market presence, potentially driving long-term sales growth and brand loyalty.
Negative Factors
Group Revenue Decline
The decline in group revenue reflects challenges in maintaining sales momentum, which may affect profitability and investor confidence if not addressed effectively.
High Input Costs in Nutrition
Rising input costs can erode profit margins, making it crucial for THG to manage costs efficiently to maintain competitiveness and profitability in the Nutrition segment.
Impact of Strategic Changes on Beauty Revenue
Strategic changes leading to revenue decline in the Beauty segment may hinder growth prospects unless offset by new initiatives or market expansions.

THG (THG) vs. iShares MSCI United Kingdom ETF (EWC)

THG Business Overview & Revenue Model

Company DescriptionTHG Plc operates as an e-commerce technology company in the United Kingdom, the United States, Europe, and internationally. The company operates pure-play sites, such as Lookfantastic, Cult Beauty, and Dermstore that offers approximately 1,300 premium brands across the skincare, haircare, cosmetics, and fragrance categories; Myprotein, a D2C sport nutrition provider that offers products across various categories, including vegan, protein, vitamin, athleisure, and healthy snacks; and THG Ingenuity, an end-to-end platform that powers businesses and brands, which offers hosting, analytics, fraud detection, logistics, and warehousing services, as well as digital brand management, including marketing, translation, and global customer services. It also engages in the online beauty and haircare businesses; and provision of skincare, haircare and cosmetics products. In addition, the company operates THG OnDemand, which offers entertainment products and subscription services for clothing, gadgets, and vinyl; THG Experience that comprises of Three luxury event spaces, including King Street Townhouse Hotel, Great John Street Hotel, and Hale Country Club & Spa; and THG Luxury, which operates various websites that retails fashion and lifestyle brands. Further, it operates hairdressing salons and hotels; offers website development, franchising and consultancy, warehouse and distribution, environmental consulting, translation and interpretation, web hosting, and marketing services; distributes motion pictures; processes films; recovers sorted metals; and produces visual content. The company was formerly known as THG Holdings plc and changed its name to THG Plc in January 2021. THG Plc was founded in 2004 and is based in Manchester, the United Kingdom.
How the Company Makes MoneyTHG generates revenue through multiple streams, primarily by selling its own branded products directly to consumers via its e-commerce platforms. The THG Beauty division offers a wide array of cosmetics and skincare products, while THG Nutrition focuses on health and wellness supplements. In addition to product sales, THG Ingenuity provides end-to-end e-commerce solutions to third-party brands, enabling them to scale their digital operations through a suite of services including web development, digital marketing, and logistics. This B2B service model is a critical revenue driver, as it allows THG to monetize its technological infrastructure and expertise. Furthermore, strategic acquisitions and partnerships with other companies expand THG's product offerings and market reach, contributing to its overall financial performance.

THG Earnings Call Summary

Earnings Call Date:Sep 11, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Apr 09, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a strong strategic focus with several positive developments such as growth in THG Nutrition, strengthening of the balance sheet, and successful disposals. However, challenges remain with group revenue decline and high input costs in Nutrition. The overall sentiment is balanced, with significant strategic achievements offset by some ongoing challenges.
Q2-2025 Updates
Positive Updates
THG Nutrition Division Growth
THG Nutrition delivered 3% revenue growth, driven by new customer acquisition and expansion of offline retail in Europe, the U.S., and Asia.
Balance Sheet Strengthening
The company reduced gross debt by GBP 374 million and extended facilities to December 2029, moving towards a net cash position.
Strong Performance in Beauty Retail
The U.K. Beauty retail business grew at its fastest rate since Q1 2024, supported by a strong U.K. market and a growing loyalty program with over 3 million members.
Successful Disposal of Claremont Ingredients
THG sold Claremont Ingredients for over GBP 100 million, marking a significant return on investment and retaining long-term supply contracts.
Myprotein Brand Growth and Expansion
Myprotein saw positive response to its global rebrand, with new customer growth and product rollouts in U.S. Walmart stores, and over 200 new products launched.
Launch of New Brands and Partnerships
Introduced over 70 major new brands on site and engaged in new licensing deals, enhancing product offerings and market presence.
Negative Updates
Group Revenue Decline
Group revenue was GBP 783 million, down 2.6% from the prior year, largely due to strategic actions within THG Beauty.
High Input Costs in Nutrition
Despite strong sales growth, high input costs in Nutrition impacted margin performance during H1.
Impact of Strategic Changes on Beauty Revenue
The majority of Beauty's H1 revenue decline was due to planned discontinuation of certain operations and sales activity withdrawal in Europe and Asia.
Timing of Large Orders Affecting Beauty Own Brands
The timing of large orders into major customers fell later this year, impacting the profitability of the Perricone MD brand in H1.
Company Guidance
In the call, THG outlined key metrics and strategic moves that have shaped its financial performance in the first half of the fiscal year 2025. The group reported a revenue of GBP 783 million, down 2.6% from the previous year, largely due to strategic shifts within THG Beauty, including the planned discontinuation of some operations. Despite this, THG Nutrition experienced a 3% revenue growth, supported by the Myprotein global rebrand and the expansion into offline retail channels. The adjusted EBITDA for H1 stood at GBP 24 million, with an EBITDA margin of approximately 3.1%, though high input costs in Nutrition impacted margins. Additionally, THG improved its financial position by reducing gross debt by GBP 374 million and extending facilities to December 2029, further strengthened by the disposal of Claremont Ingredients for over GBP 100 million. Looking ahead, THG remains confident in its full-year guidance, bolstered by positive growth in both Beauty and Nutrition divisions and strategic actions aimed at enhancing market share and customer loyalty. The company is also exploring growth opportunities in retail media and licensing to expand its brand presence globally.

THG Financial Statement Overview

Summary
THG is facing significant financial challenges with declining revenues, high leverage, and ongoing losses. Despite improvements in cash flow management, the company's ability to achieve sustainable profitability remains uncertain. Continued focus on reducing debt and enhancing operational efficiencies is critical.
Income Statement
45
Neutral
THG has faced substantial challenges in maintaining profitability, as reflected by negative net income margins over recent years. The revenue has declined from 2023 to 2024 by 14.3%, and a negative EBIT margin further underscores operational challenges. The company has seen inconsistent gross profit margins, indicating difficulties in cost management. While there are signs of improvement in EBITDA margins compared to 2023, overall performance remains fragile.
Balance Sheet
50
Neutral
The balance sheet shows a high debt-to-equity ratio of 2.11 in 2024, suggesting significant leverage which may pose risks. The equity ratio has decreased to 12.0%, indicating reduced financial stability. Return on Equity (ROE) remains negative due to persistent net losses. Despite these challenges, the company has managed to reduce net debt, pointing to some improvement in financial management.
Cash Flow
55
Neutral
THG's cash flow statement reveals a positive growth trend in free cash flow, improving from a small positive value in 2023 to 28.99 million in 2024. The operating cash flow to net income ratio suggests that cash flows are more stable than net income figures would suggest. However, the free cash flow to net income remains low, indicating potential issues with converting earnings into cash.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.75B2.05B2.24B2.18B1.61B
Gross Profit693.60M840.29M771.00M855.37M655.91M
EBITDA-48.64M42.42M-289.44M32.07M-376.33M
Net Income-326.14M-248.37M-539.96M-138.07M-532.63M
Balance Sheet
Total Assets2.55B2.78B3.09B3.42B2.45B
Cash, Cash Equivalents and Short-Term Investments309.35M416.16M473.78M536.83M773.58M
Total Debt645.94M995.01M1.01B839.04M762.34M
Total Liabilities2.24B1.76B1.79B1.67B1.30B
Stockholders Equity305.83M1.02B1.30B1.76B1.14B
Cash Flow
Free Cash Flow28.99M16.15M-164.27M-190.88M-198.98M
Operating Cash Flow60.70M141.81M12.15M-1.71M40.39M
Investing Cash Flow-92.11M-77.14M-182.11M-959.06M-351.32M
Financing Cash Flow-22.91M-122.29M106.92M724.01M772.28M

THG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price35.82
Price Trends
50DMA
30.98
Positive
100DMA
29.12
Positive
200DMA
33.59
Positive
Market Momentum
MACD
1.11
Negative
RSI
66.61
Neutral
STOCH
91.53
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:THG, the sentiment is Positive. The current price of 35.82 is above the 20-day moving average (MA) of 30.07, above the 50-day MA of 30.98, and above the 200-day MA of 33.59, indicating a bullish trend. The MACD of 1.11 indicates Negative momentum. The RSI at 66.61 is Neutral, neither overbought nor oversold. The STOCH value of 91.53 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:THG.

THG Risk Analysis

THG disclosed 12 risk factors in its most recent earnings report. THG reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

THG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
86
Outperform
384.30M7.9413.78%4.39%6.19%-4.44%
59
Neutral
563.80M54.157.27%9.45%-57.24%
52
Neutral
£552.49M-18.75%-20.36%
46
Neutral
331.79M-1.13-64.97%-15.86%-18.46%
46
Neutral
689.09M-71.7233.36%0.47%2.62%-129.82%
38
Underperform
168.14M-0.50-8369.23%-45.91%-120.22%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:THG
THG
35.82
-16.38
-31.38%
GB:ASC
ASOS plc
278.00
-152.60
-35.44%
GB:CARD
Card Factory
109.40
-26.52
-19.51%
GB:DEBS
boohoo group Plc
13.06
-15.72
-54.62%
GB:AO
AO World
99.10
-7.50
-7.04%
GB:MOON
Moonpig Group Plc
213.00
6.91
3.35%

THG Corporate Events

Business Operations and StrategyFinancial DisclosuresM&A Transactions
THG PLC Reports Interim Results with Strategic Growth in Beauty and Nutrition
Positive
Sep 11, 2025

THG PLC reported its interim results for the first half of 2025, showing a return to revenue growth in the second quarter, driven by strategic changes in its beauty and nutrition divisions. The company completed a successful demerger of THG Ingenuity and disposed of Claremont Ingredients, which, along with refinancing, improved its net cash position. Despite a slight decline in overall group revenue, THG anticipates stronger performance in the second half, supported by increased brand partnerships and market share gains, particularly in the UK beauty sector and Myprotein’s expansion in offline retail and licensing.

The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Financial Disclosures
THG PLC to Announce Interim Results for H1 2025
Neutral
Sep 10, 2025

THG PLC announced that it will release its interim results for the six months ending 30 June 2025 on 11 September 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor confidence.

The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
THG PLC Announces Leadership Appointment at Vistry Group
Neutral
Sep 5, 2025

THG PLC has announced that Sue Farr, currently serving as the Senior Independent Director, will be joining Vistry Group PLC as a non-executive director starting from October 1, 2025. This move signifies a strategic alignment and potential collaboration between the two companies, which could influence THG’s market positioning and stakeholder relations.

The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Business Operations and StrategyM&A Transactions
THG PLC Divests Claremont Ingredients for £103 Million
Positive
Aug 6, 2025

THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This move aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was originally acquired for £52 million in 2020. Financially, the disposal will aid in reducing THG’s net leverage and borrowing costs. Operationally, the relationship with Claremont will continue through a long-term supply contract, ensuring Myprotein’s flavour capabilities remain robust. The transaction is expected to impact THG’s EBITDA in the coming years, but the company anticipates double-digit revenue growth for THG Nutrition in the second half of 2025, driven by stable whey prices and strategic pricing approaches to enhance market share.

The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Business Operations and StrategyM&A Transactions
THG PLC Sells Claremont Ingredients to Nactarome Group for £103 Million
Neutral
Aug 6, 2025

THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This divestment aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was acquired for £52 million in 2020. Financially, the disposal will help reduce THG’s net leverage and borrowing costs, although it is expected to decrease the Group’s EBITDA for FY 2025 and FY 2026 by £5 million and £10 million, respectively. The strategic move is part of THG’s broader plan to focus on core strengths and market share growth, particularly for its Myprotein brand, which is expected to see double-digit revenue growth in the second half of 2025.

The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Executive/Board Changes
THG PLC Announces Changes to Board Committee Roles
Neutral
Jul 9, 2025

THG PLC has announced changes to its Board Committee memberships. Milyae Park, an independent Non-Executive Director, has been appointed to the Audit and Risk Committees and the Sustainability Committee. Additionally, Helen Jones, another independent Non-Executive Director, will now serve as the designated Non-Executive Director for workforce engagement. These changes are expected to enhance the company’s governance and engagement with its workforce, potentially impacting its operational efficiency and stakeholder relations.

The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 12, 2025